Advertisement HealthTronics acquires UroPath - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

HealthTronics acquires UroPath

HealthTronics, a provider of urology services and products, has acquired UroPath, a provider of anatomical pathology laboratory services, for $7.5 million.

James Whittenburg, CEO of HealthTronics, said: “HealthTronics brings deep and capable resources to bear in restructuring the existing UroPath model to fully address the regulatory environment while preserving, to the greatest extent possible, the tangible patient and quality of care benefits.

“Our existing laboratory, ClariPath, adds significant flexibility and efficiencies as we refine the UroPath business model.”